Cloning_VBG and_CC characterisation_NN of_IN hAps1_JJ and_CC hAps2_JJ ,_, human_JJ diadenosine_NN polyphosphate-metabolising_VBG Nudix_NP hydrolases_NNS Abstract_NP |_SYM Background_NN |_SYM The_DT human_JJ genome_NN contains_VBZ at_IN least_JJS 18_CD genes_NNS for_IN Nudix_NP hydrolase_NN enzymes_NNS ._SENT Many_JJ have_VBP similar_JJ functions_NNS to_TO one_CD another_DT ._SENT In_IN order_NN to_TO understand_VB their_PP$ roles_NNS in_IN cell_NN physiology_NN ,_, these_DT proteins_NNS must_MD be_VB characterised_VBN ._SENT Results_NNS |_SYM We_PP have_VBP characterised_VBN two_CD novel_NN human_JJ gene_NN products_NNS ,_, hAps1_JJ ,_, encoded_VBN by_IN the_DT NUDT11_JJ gene_NN ,_, and_CC hAps2_NN ,_, encoded_VBN by_IN the_DT NUDT10_NP gene_NN ._SENT These_DT cytoplasmic_JJ proteins_NNS are_VBP members_NNS of_IN the_DT DIPP_NP subfamily_NN of_IN Nudix_NP hydrolases_NNS ,_, and_CC differ_VBP from_IN each_DT other_JJ by_IN a_DT single_JJ amino_NN acid_NN ._SENT Both_CC metabolise_VB diadenosine-polyphosphates_NNS and_CC ,_, weakly_RB ,_, diphosphoinositol_NN polyphosphates_NNS ._SENT An_DT apparent_JJ polymorphism_NN of_IN hAps1_NN has_VBZ also_RB been_VBN identified_VBN ,_, which_WDT leads_VBZ to_TO the_DT point_NN mutation_NN S39N_NP ._SENT This_DT has_VBZ also_RB been_VBN characterised_VBN ._SENT The_DT favoured_VBN nucleotides_NNS were_VBD diadenosine_JJ 5',5"'-pentaphosphate_NN (_( kcat/Km_NN =_SYM 11_CD ,_, 8_CD and_CC 16_CD x_SYM 103M-1s-1_JJ respectively_RB for_IN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_NN )_) and_CC diadenosine_NN 5',5"'-hexaphosphate_NN (_( kcat/Km_NN =_SYM 13_CD ,_, 14_CD and_CC 11_CD x_SYM 103M-1s-1_JJ respectively_RB for_IN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_NN )_) ._SENT Both_DT hAps1_NN and_CC hAps2_NN had_VBD pH_NN optima_NNS of_IN 8.5_CD and_CC an_DT absolute_JJ requirement_NN for_IN divalent_JJ cations_NNS ,_, with_IN manganese_NN (_( II_NP )_) being_VBG favoured_VBN ._SENT Magnesium_NN was_VBD not_RB able_JJ to_TO activate_VB the_DT enzymes_NNS ._SENT Therefore_RB ,_, these_DT enzymes_NNS could_MD be_VB acutely_RB regulated_VBN by_IN manganese_NN fluxes_NNS within_IN the_DT cell_NN ._SENT Conclusions_NNS |_SYM Recent_JJ gene_NN duplication_NN has_VBZ generated_VBN the_DT two_CD Nudix_NP genes_NNS ,_, NUDT11_NP and_CC NUDT10_NP ._SENT We_PP have_VBP characterised_VBN their_PP$ gene_NN products_NNS as_IN the_DT closely_RB related_VBN Nudix_NP hydrolases_NNS ,_, hAps1_JJ and_CC hAps2_JJ ._SENT These_DT two_CD gene_NN products_NNS complement_VB the_DT activity_NN of_IN previously_RB described_VBN members_NNS of_IN the_DT DIPP_NP family_NN ,_, and_CC reinforce_VB the_DT concept_NN that_IN Ap5A_NP and_CC Ap6A_NP act_NN as_IN intracellular_JJ messengers_NNS ._SENT In_IN addition_NN to_TO the_DT canonical_JJ ribonucleoside_NN and_CC deoxyribonucleoside_NN phosphates_NNS and_CC cofactors_NNS ,_, cells_NNS contain_VBP a_DT large_JJ number_NN of_IN minor_JJ nucleotides_NNS ._SENT Among_IN these_DT are_VBP the_DT diadenosine_JJ polyphosphates_NNS (_( ApnA_NP ,_, where_WRB n_NN =_SYM 2_CD --_: 7_CD )_) ._SENT Ap3A_NP and_CC Ap4A_NP are_VBP the_DT most_RBS intensively_RB studied_VBN of_IN these_DT and_CC are_VBP generally_RB present_JJ in_IN the_DT soluble_JJ fraction_NN of_IN eukaryotic_JJ and_CC prokaryotic_JJ cells_NNS at_IN concentrations_NNS between_IN 10_CD nM_NN and_CC 5_CD muM_NN ._SENT Platelet_NN dense_JJ granules_NNS ,_, adrenal_JJ chromaffin_NN granules_NNS and_CC certain_JJ synaptic_JJ vesicles_NNS have_VBP been_VBN reported_VBN to_TO contain_VB high_JJ concentrations_NNS of_IN Ap5A_NP and_CC Ap6A_NP in_IN addition_NN to_TO Ap3A_NP and_CC Ap4A_NP ,_, all_DT of_IN which_WDT can_MD be_VB exocytosed_VBN following_VBG appropriate_JJ stimuli_NNS and_CC bind_NN to_TO target_VB cell_NN purinoceptors_NNS causing_VBG a_DT variety_NN of_IN physiological_JJ responses_NNS in_IN the_DT cardiovascular_JJ and_CC central_JJ and_CC peripheral_JJ nervous_JJ systems_NNS [_SYM ,-_NN ]_SYM ._SENT However_RB ,_, although_IN Ap6A_NP has_VBZ been_VBN detected_VBN in_IN erythrocytes_NNS ,_, there_EX are_VBP no_RB substantiated_VBN measurements_NNS of_IN Ap5A_NP and_CC Ap6A_NP in_IN the_DT soluble_JJ fraction_NN of_IN nucleated_VBN cells_NNS ,_, and_CC it_PP is_VBZ likely_JJ that_IN they_PP are_VBP typically_RB present_JJ at_IN concentrations_NNS much_RB lower_JJR than_IN those_DT of_IN Ap3A_NP and_CC Ap4A_NP ._SENT The_DT estimated_VBN 7_CD muM_NN Ap5A_NP reported_VBD in_IN cardiac_JJ muscle_NN may_MD also_RB be_VB confined_VBN to_TO granules_NNS ._SENT Whilst_IN the_DT extracellular_JJ diadenosine_NN polyphosphates_NNS have_VBP partially_RB characterised_VBN signalling_VBG properties_NNS ,_, the_DT possible_JJ functions_NNS of_IN the_DT soluble_JJ ,_, intracellular_JJ compounds_NNS remain_VBP unclear_JJ ._SENT On_IN the_DT one_CD hand_NN ,_, they_PP may_MD simply_RB be_VB by-products_NNS of_IN several_JJ enzymic_JJ reactions_NNS (_( e.g._FW those_DT catalysed_VBN by_IN aminoacyl-tRNA_NN synthetases_NNS and_CC other_JJ ligases_NNS )_) ._SENT On_IN the_DT other_JJ ,_, they_PP may_MD have_VB one_CD or_CC more_JJR of_IN a_DT number_NN of_IN important_JJ regulatory_JJ roles_NNS ,_, including_VBG involvements_NNS in_IN DNA_NP replication/repair_NP ,_, metabolic_JJ stress_NN responses_NNS ,_, the_DT determination_NN of_IN cellular_JJ fate_NN ,_, and_CC the_DT regulation_NN of_IN enzyme_NN activities_NNS and_CC ion_NN channels_NNS (_( see_VB )_) ._SENT For_IN example_NN ,_, Ap5A_NP is_VBZ a_DT potent_JJ inhibitor_NN of_IN adenylate_JJ kinase_NN ._SENT It_PP is_VBZ clear_JJ that_IN cells_NNS have_VBP a_DT variety_NN of_IN relatively_RB specific_JJ enzymes_NNS able_JJ to_TO degrade_VB these_DT compounds_NNS ._SENT These_DT include_VBP symmetrically-cleaving_JJ Ap4A_NP hydrolases_NNS (_( in_IN prokaryotes_NNS )_) ,_, members_NNS of_IN the_DT histidine_NN triad_NN protein_NN family_NN such_JJ as_IN the_DT FHIT_NP tumour_NN suppresser_NN protein_NN and_CC (_( in_IN lower_JJR eukaryotes_NNS )_) the_DT related_JJ Ap4A_NP phosphorylases_NNS ,_, and_CC most_RBS widespread_JJ of_IN all_DT ,_, members_NNS of_IN the_DT Nudix_NP hydrolase_NN family_NN (_( see_VB for_IN reviews_NNS )_) ._SENT Nudix_NN hydrolases_NNS cleave_VBP predominantly_RB the_DT diphosphate_NN linkage_NN in_IN compounds_NNS of_IN general_JJ structure_NN :_: nucleoside_NN diphosphate_NN linked_VBN to_TO another_DT moiety_NN ,_, X._NP Some_DT family_NN members_NNS have_VBP a_DT relatively_RB broad_JJ substrate_NN specificity_NN ,_, while_IN others_NNS have_VBP a_DT much_RB more_RBR restricted_JJ range_NN ._SENT They_PP all_RB possess_VBP the_DT Nudix_NP sequence_NN signature_NN motif_NN Gx5Ex5_NP [_SYM UA]xREx2EexGU_NP (_( where_WRB U_NP is_VBZ an_DT aliphatic_JJ hydrophobic_JJ amino_NN acid_NN )_) ,_, which_WDT represents_VBZ the_DT catalytic_JJ site_NN of_IN the_DT enzyme_NN ._SENT Animal_NN and_CC plant_VB Ap4A_NP hydrolases_NNS (_( EC_NP 3.1.6.17_CD )_) degrade_VBP Ap4A_NP ,_, Ap5A_NP and_CC Ap6A_NP ,_, always_RB producing_VBG ATP_NP as_IN one_CD of_IN the_DT products_NNS ._SENT They_PP are_VBP most_RBS active_JJ towards_IN Ap4A_NP ;_: however_RB ,_, the_DT related_JJ enzymes_NNS from_IN Escherichia_NP coli_NNS and_CC Rickettsia_NP prowazekii_NNS show_VBP a_DT marked_JJ preference_NN for_IN Ap5A_NP ._SENT More_RBR recently_RB ,_, distinct_JJ members_NNS of_IN the_DT Nudix_NP family_NN that_WDT prefer_VBP Ap6A_NP have_VBP been_VBN purified_VBN and_CC characterised_VBN ._SENT The_DT three_CD human_JJ enzymes_NNS termed_VBD diphosphoinositol_NN polyphosphate_NN phosphohydrolases_NNS 1_CD ,_, 2alpha_NP and_CC 2beta_NP (_( hDIPP-1_NP ,_, -2alpha_NN and_CC -2beta_NNS )_) as_RB well_RB as_IN Schizosaccharomyces_NP pombe_NN Aps1_NP and_CC Saccharomyces_NP cerevisiae_NP Ddp1p_NP all_DT favour_NN Ap6A_NP over_IN Ap5A_NP ._SENT Activity_NN with_IN Ap4A_NP is_VBZ lower_JJR ,_, and_CC is_VBZ in_IN fact_NN lacking_VBG in_IN the_DT case_NN of_IN Ddp1p_NP ._SENT Remarkably_RB these_DT Ap6A_NP hydrolases_NNS are_VBP also_RB able_JJ to_TO utilise_VB the_DT structurally_RB unrelated_JJ non-nucleotide_NN substrates_NNS ,_, diphosphoinositol_NN pentakisphosphate_NN (_( PP-InsP5_NP )_) and_CC bis-diphosphoinositol_NN tetrakisphosphate_NN (_( [_SYM PP]2-InsP4_NP )_) ,_, hence_RB they_PP are_VBP commonly_RB referred_VBN to_TO as_IN the_DT DIPP_NP subfamily_NN ._SENT These_DT substrates_NNS are_VBP generally_RB favoured_VBN in_IN vitro_NN ,_, with_IN kcat/Km_NN ratios_NNS being_VBG 50_CD --_: 500-fold_NN higher_JJR for_IN PP-InsP5_NP compared_VBN to_TO Ap6A_NP ,_, except_IN for_IN DIPP-2beta_NP ,_, which_WDT has_VBZ a_DT significantly_RB reduced_VBN relative_JJ activity_NN with_IN PP-InsP5_NP compared_VBN to_TO the_DT others_NNS ._SENT The_DT intracellular_JJ levels_NNS of_IN diphosphoinositol_NN polyphosphates_NNS appear_VBP to_TO be_VB lower_JJR than_IN those_DT of_IN the_DT nucleotide_NN substrates_NNS ._SENT PP-InsP5_JJ levels_NNS are_VBP often_RB between_IN 1_CD and_CC 3_CD %_NN of_IN the_DT levels_NNS of_IN InsP6_NP ,_, which_WDT has_VBZ been_VBN estimated_VBN as_IN being_VBG between_IN 15_CD and_CC 100_CD muM_NN (_( see_VB )_) and_CC [_SYM PP]2-InsP4_JJ levels_NNS are_VBP an_DT order_NN of_IN magnitude_NN lower_RBR ,_, and_CC as_RB such_JJ are_VBP virtually_RB undetectable_JJ in_IN many_JJ cell_NN types_NNS ._SENT PP-InsP5_JJ turnover_NN is_VBZ regulated_VBN by_IN the_DT tumour_NN promoter_NN thapsigargin_NN ,_, while_NN [_SYM PP]2-InsP4_JJ turnover_NN is_VBZ regulated_VBN by_IN cyclic_JJ AMP-_NN and_CC cyclic_JJ GMP-dependent_JJ processes_NNS via_IN an_DT undefined_JJ mechanism_NN ._SENT However_RB ,_, as_RB for_IN the_DT ApnAs_NP ,_, no_DT clear_JJ functions_NNS have_VBP yet_RB been_VBN found_VBN for_IN the_DT diphosphoinositol_NN polyphosphates_NNS ,_, although_IN they_PP have_VBP been_VBN implicated_VBN in_IN vesicle_NN trafficking_NN ,_, apoptosis_NN and_CC DNA_NN repair_NN ._SENT We_PP describe_VBP here_RB two_CD further_JJR members_NNS of_IN the_DT human_JJ DIPP_NP subfamily_NN with_IN novel_NN properties_NNS ._SENT These_DT proteins_NNS ,_, hAps1_JJ and_CC hAps2_JJ ,_, products_NNS of_IN the_DT NUDT11_NP and_CC NUDT10_NP genes_NNS respectively_RB ,_, closely_RB resemble_VBP the_DT other_JJ DIPPs_NN in_IN primary_JJ structure_NN ,_, but_CC show_VB a_DT selectivity_NN towards_IN Ap5A_NP and_CC Ap6A_NP and_CC reduced_VBN activity_NN towards_IN PP-InsP5_NP and_NP [_SYM PP]2-InsP4_NP ._SENT They_PP also_RB display_VBP a_DT novel_JJ pattern_NN of_IN tissue-specific_JJ expression_NN ._SENT Sequence_NN alignment_NN |_SYM An_DT initial_JJ BLAST_NN search_NN of_IN the_DT GenBank_NP expressed_VBD sequence_NN tag_NN (_( EST_JJ )_) database_NN with_IN the_DT hDIPP-1_JJ sequence_NN identified_VBD two_CD closely_RB related_VBN but_CC previously_RB uncharacterised_VBD predicted_VBN proteins_NNS ,_, which_WDT we_PP have_VBP called_VBN hAps1_JJ and_CC hAps2_JJ (_( human_JJ ApsixA_NP hydrolases_NNS 1_CD and_CC 2_CD )_) ._SENT Alignment_NN of_IN the_DT cDNA_NN sequences_NNS with_IN the_DT human_JJ genome_NN indicated_VBD that_IN the_DT genomic_JJ sequences_NNS encoding_VBG these_DT proteins_NNS ,_, FLJ10628_NP and_CC LOC139770_NP ,_, lie_VBP about_RB 150_CD kb_NN apart_RB on_IN the_DT X_NP chromosome_NN at_IN Xp11.23_NP and_CC are_VBP transcribed_VBN in_IN opposite_JJ directions_NNS ._SENT In_IN accordance_NN with_IN the_DT guidelines_NNS for_IN the_DT Nudix_NP protein_NN family_NN ,_, the_DT genes_NNS for_IN hAps1_JJ and_CC hAps2_JJ have_VBP been_VBN designated_VBN NUDT11_JJ and_CC NUDT10_JJ respectively_RB by_IN the_DT HUGO_NP Gene_NP Nomenclature_NP Committee_NP (_( see_VB )_) ._SENT These_DT proteins_NNS are_VBP each_DT 164_CD amino_NN acids_NNS long_JJ and_CC are_VBP most_RBS similar_JJ to_TO hDIPP-2beta_NN ,_, hAps1_JJ showing_NN 76_CD ,_, 90_CD and_CC 91_CD %_NN identity_NN at_IN the_DT amino_NN acid_NN level_NN to_TO hDIPP-1_JJ ,_, 2alpha_JJ and_CC 2beta_JJ ,_, respectively_RB ._SENT In_IN particular_JJ ,_, they_PP both_CC possess_VB the_DT additional_JJ Gln_NP residue_NN (_( Q86_NP in_IN DIPP-2beta_NP )_) that_WDT distinguishes_VBZ hDIPP-2beta_NN from_IN hDIPP-2alpha_NN and_CC hDIPP-1_JJ and_CC which_WDT is_VBZ responsible_JJ for_IN the_DT reduced_VBN activity_NN of_IN hDIPP-2beta_NN towards_IN diphosphoinositol_NN polyphosphates_NNS compared_VBN to_TO the_DT other_JJ DIPPs_NP ._SENT hAps1_JJ and_CC hAps2_JJ are_VBP also_RB identical_JJ to_TO the_DT hDIPP-2_JJ enzymes_NNS throughout_IN the_DT Nudix_NP motif_NN ._SENT These_DT observations_NNS led_VBD us_PP to_TO anticipate_VB that_DT hAps1_NN and_CC hAps2_NN would_MD be_VB potent_JJ dinucleoside_NN polyphosphate_NN hydrolases_NNS with_IN reduced_VBN activity_NN towards_IN diphosphoinositol_NN polyphosphates_NNS ._SENT The_DT existence_NN of_IN two_CD such_JJ similar_JJ expressed_VBN gene_NN products_NNS was_VBD surprising_JJ ._SENT Comparison_NN of_IN the_DT open_JJ reading_NN frames_NNS (_( ORFs_NP )_) of_IN hAps1_NN and_CC hAps2_NN revealed_VBD 6_CD differences_NNS at_IN the_DT nucleotide_NN level_NN ,_, leading_VBG to_TO five_CD silent_JJ changes_NNS (_( T8_NP ,_, E28_NP ,_, E69_NP ,_, D88_NP and_CC stop_VB )_) ,_, and_CC an_DT Arg-Pro_NP substitution_NN at_IN position_NN 89_CD ._SENT A_DT comparison_NN of_IN the_DT cDNAs_NNS for_IN the_DT two_CD gene_NN products_NNS showed_VBD further_JJR divergence_NN in_IN the_DT 3_CD '_POS untranslated_JJ region_NN ._SENT It_PP appears_VBZ that_IN the_DT evolution_NN of_IN these_DT closely_RB related_VBN genes_NNS occurred_VBD recently_RB ,_, as_IN hAps1_JJ and_CC hAps2_JJ show_VBP greater_JJR similarity_NN with_IN each_DT other_JJ than_IN with_IN the_DT Aps-like_JJ sequences_NNS from_IN mouse_NN (_( of_IN which_WDT two_CD genes_NNS ,_, XM_135784_NP and_CC XM_135786_NP appear_VBP to_TO yield_VB the_DT same_JJ protein_NN product_NN )_) or_CC cow_NN ._SENT Further_JJR examination_NN of_IN all_DT available_JJ hAps1_JJ ESTs_NN revealed_VBD a_DT sequence_NN divergence_NN ,_, leading_VBG to_TO a_DT point_NN mutation_NN S39N_NP ,_, in_IN the_DT coding_VBG region_NN ._SENT This_DT is_VBZ present_JJ in_IN two_CD ESTs_NN and_CC was_VBD detected_VBN in_IN 10_CD %_NN (_( 3_CD from_IN 30_CD )_) of_IN polymerase_NN chain_NN reaction_NN (_( PCR_NP )_) products_NNS generated_VBN from_IN a_DT range_NN of_IN normal_JJ human_JJ cDNA_NN samples_NNS from_IN diverse_JJ sources_NNS ._SENT In_IN all_DT other_JJ respects_NNS investigated_VBD ,_, including_VBG the_DT 3_CD '_POS untranslated_JJ region_NN ,_, it_PP appeared_VBD to_TO be_VB identical_JJ to_TO hAps1_NN ._SENT This_DT would_MD suggest_VB that_IN this_DT minor_JJ variant_NN ,_, hAps1-39N_NP ,_, represents_VBZ a_DT polymorphism_NN present_NN in_IN the_DT human_JJ population_NN ._SENT Its_PP$ properties_NNS were_VBD also_RB examined_VBN in_IN this_DT study_NN ._SENT Figure_NP 1_CD |_SYM The_DT NUDT11/NUDT10_JJ region_NN of_IN chromosome_NN Xp11_JJ ._SENT The_DT NUDT11/NUDT10_NP region_NN of_IN chromosome_NN Xp11.23_NP ._SENT The_DT two_CD known_VBN exons_NNS of_IN NUDT11_NP ,_, encoding_VBG hAps1_JJ ,_, and_CC NUDT10_NP ,_, encoding_VBG hAps2_NN are_VBP shown_VBN represented_VBN as_IN boxes_NNS ._SENT Introns_NNS are_VBP represented_VBN by_IN angled_VBN connecting_VBG lines_NNS ._SENT The_DT coding_VBG region_NN of_IN each_DT gene_NN is_VBZ shaded_JJ ._SENT Solid_JJ arrows_NNS indicate_VBP the_DT direction_NN of_IN transcription_NN of_IN each_DT gene_NN ._SENT Figure_NP 2_CD |_SYM Sequence_NN alignment_NN of_IN hAps1_JJ ,_, hAps2_JJ ,_, hDIPP-1_JJ and_CC hDIPP-2_JJ (_( alpha_NN and_CC beta_NN )_) ._SENT Sequence_NN alignment_NN of_IN hAps1_JJ ,_, hAps2_JJ ,_, hDIPP-1_JJ and_CC hDIPP-2_JJ (_( alpha_NN and_CC beta_NN )_) ._SENT The_DT figure_NN shows_VBZ an_DT alignment_NN of_IN the_DT amino_NN acid_NN sequences_NNS of_IN hAps1_JJ ,_, hAps2_JJ ,_, hDIPP-1_JJ and_CC hDIPP-2_JJ (_( alpha_NN and_CC beta_NN )_) ,_, generated_VBN by_IN the_DT MAP_NP algorithm_NN ._SENT Black_JJ shading_NN denotes_VBZ amino_NN acids_NNS in_IN at_IN least_JJS two_CD of_IN the_DT proteins_NNS were_VBD identical_JJ ._SENT Physicochemical_JJ similarity_NN is_VBZ denoted_VBN by_IN grey_JJ shading_NN ._SENT Figure_NP 3_CD |_SYM Comparison_NN of_IN hAps1_NN with_IN translated_VBN EST_JJ sequences_NNS from_IN mouse_NN and_CC cow_NN ._SENT Comparison_NN of_IN hAps1_NN with_IN translated_VBN EST_JJ sequences_NNS from_IN mouse_NN and_CC cow_NN ._SENT No_DT full-length_JJ bovine_JJ EST_NN for_IN the_DT hAps1_JJ homologue_NN is_VBZ available_JJ ,_, hence_RB the_DT composite_NN of_IN two_CD separate_JJ sequences_NNS is_VBZ shown_VBN ._SENT A_DT predicted_VBN rat_NN protein_NN from_IN genomic_JJ sequencing_NP is_VBZ also_RB shown_VBN ._SENT Table_NP 1_CD |_SYM Tissue_JJ sources_NNS of_IN known_VBN ESTs_NNS for_IN hAps1_JJ and_CC hAps2_JJ Purification_NN and_CC properties_NNS of_IN hAps1_NN and_CC hAps2_NNS |_SYM The_DT ORFs_NNS for_IN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_NN were_VBD cloned_VBN into_IN the_DT pGEX6P-1_JJ expression_NN vector_NN and_CC expressed_VBN in_IN Escherichia_NP coli_NNS (_( E._NP coli_NNS )_) ._SENT After_IN incubation_NN with_IN isopropyl_NN beta-D-thiogalactoside_NN (_( IPTG_NP )_) (_( 100_CD muM_NN )_) at_IN 26C_JJ for_IN 8_CD hours_NNS ,_, a_DT major_JJ protein_NN of_IN the_DT expected_VBN size_NN was_VBD induced_VBN and_CC expressed_VBN in_IN a_DT soluble_JJ form_NN in_IN each_DT case_NN ._SENT The_DT glutathione_NN S-transferase_NN (GST)-tagged_VBD recombinant_JJ proteins_NNS were_VBD purified_VBN by_IN chromatography_NN on_IN Glutathione_NP Sepharose_NP 4_CD Fast_NP Flow_NP resin_NN ._SENT Figure_NP 4_CD |_SYM SDS-PAGE_NN of_IN purified_VBN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_NN ._SENT SDS-PAGE_NN of_IN purified_VBN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_NN ._SENT GST-tagged_JJ hAps_NNS proteins_NNS were_VBD prepared_VBN as_IN described_VBN under_IN "_`` Materials_NNS and_CC methods_NNS "_'' ._SENT Approximately_RB 10_CD mug_NN of_IN (_( a_DT )_) hAps1_NN ,_, (_( b_LS )_) hAps1-39N_NNS and_CC (_( c_LS )_) hAps2_NN were_VBD analysed_VBN by_IN SDS-PAGE_NP ._SENT Purity_NN was_VBD determined_VBN by_IN Coomassie-blue_NP staining_VBG a_DT 4_CD --_: 12_CD %_NN Bis-Tris_NP NuPage_NP gel_NN (_( Novex_NP )_) ._SENT Molecular_JJ weight_NN standards_NNS (_( MultiMark_NP multi-colored_NN standards_NNS )_) were_VBD from_IN Novex_NP ._SENT Initially_RB ,_, the_DT ability_NN of_IN hAps1_JJ and_CC hAps2_JJ to_TO metabolise_VB Ap5A_NP was_VBD determined_VBN at_IN 37C_JJ in_IN the_DT presence_NN of_IN 50_CD mM_NP HEPES_NP ,_, pH_NN 7.6_CD and_CC 100_CD muM_NN substrate_NN ._SENT A_DT divalent_JJ cation_NN was_VBD essential_JJ for_IN activity_NN ,_, with_IN Mn2+_NP by_IN far_RB the_DT most_RBS effective_JJ between_IN 2_CD and_CC 6_CD mM_NNS ._SENT Cu2+_NP supported_VBD less_JJR than_IN 30_CD %_NN and_CC Zn2+_NP and_CC Co2+_NP each_DT less_JJR than_IN 3_CD %_NN of_IN the_DT maximum_JJ activity_NN ._SENT Ni2+_NP ,_, Ca2+_NP and_CC ,_, surprisingly_RB ,_, Mg2+_NP were_VBD unable_JJ to_TO activate_VB hAps1_JJ or_CC hAps2_JJ ._SENT When_WRB assayed_VBN in_IN the_DT presence_NN of_IN 1_CD mM_NP MnCl2_NP ,_, hAps1_NN and_CC hAps2_NN showed_VBD alkaline_JJ pH_NN optima_NNS of_IN pH_NN 8.5_CD ,_, a_DT feature_NN common_JJ among_IN Nudix_NP hydrolases_NNS ._SENT Activity_NN increased_VBD from_IN undetectable_JJ at_IN pH_NN 6_CD to_TO over_RB 70_CD %_NN maximum_NN between_IN 7.5_CD and_CC 9_CD ._SENT Previous_JJ characterisation_NN of_IN hDIPP-1_JJ ,_, 2alpha_JJ and_CC 2beta_JJ ,_, as_RB well_RB as_IN S._NP pombe_NN Aps1_NP was_VBD performed_VBN in_IN a_DT buffer_NN containing_VBG 1_CD mM_NP MnCl2_NP at_IN pH_NN 7.6_CD ._SENT In_IN order_NN to_TO compare_VB results_NNS for_IN hAps1_JJ and_CC hAps2_JJ directly_RB with_IN hDIPP-1_JJ ,_, hDIPP-2_JJ and_CC S._NP pombe_NN Aps1_NP ,_, we_PP have_VBP performed_VBN assays_NNS using_VBG identical_JJ conditions_NNS ._SENT Figure_NP 5_CD |_SYM Properties_NP of_IN hAps1_JJ and_CC hAps2_JJ ._SENT Properties_NNS of_IN hAps1_JJ and_CC hAps2_JJ ._SENT (_( a_DT )_) Mn2+-dependency_NN of_IN hAps1_JJ (_( filled_VBN circles_NNS )_) and_CC hAps2_JJ (_( open_JJ circles_NNS )_) activity_NN towards_IN Ap5A_NP (_( 100_CD muM_NN )_) ._SENT (_( b_LS )_) pH_NN dependency_NN of_IN hAps1_JJ (_( filled_VBN circles_NNS )_) and_CC hAps2_JJ (_( open_JJ circles_NNS )_) activity_NN towards_IN Ap5A_NP (_( 100_CD muM_NN )_) ._SENT When_WRB hAps1_JJ ,_, hAps1-39N_NN and_CC hAps2_NN were_VBD assayed_VBN with_IN a_DT wide_JJ range_NN of_IN potential_JJ substrates_NNS all_DT three_CD proteins_NNS were_VBD found_VBN ,_, as_IN expected_VBN ,_, to_TO metabolise_VB Ap5A_NP and_CC Ap6A_NP ._SENT Of_IN the_DT other_JJ substrates_NNS tested_VBD ,_, only_RB p4A_NN and_CC p4G_NN showed_VBD significant_JJ rates_NNS of_IN hydrolysis_NN by_IN all_DT three_CD ,_, while_IN Ap4A_NP and_CC Gp4G_NP were_VBD also_RB effective_JJ substrates_NNS for_IN hAps2_NN ._SENT All_DT three_CD enzymes_NNS showed_VBD a_DT marked_JJ preference_NN for_IN adenine_NN over_IN guanine_NN nucleotides_NNS ._SENT Table_NN shows_VBZ rates_NNS of_IN metabolism_NN and_CC products_NNS formed_VBD where_WRB identified_VBN ._SENT Km_NN and_CC kcat_NN values_NNS for_IN each_DT enzyme_NN with_IN Ap5A_NP and_CC Ap6A_NP are_VBP shown_VBN in_IN Table_NP ._SENT The_DT most_RBS rapidly_RB metabolised_VBN substrate_NN appeared_VBD to_TO be_VB Ap5A_NP ,_, although_IN Ap6A_NP was_VBD bound_VBN with_IN higher_JJR affinity_NN ._SENT Table_NP 2_CD |_SYM Nucleotide_NN substrate_NN utilisation_NN by_IN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_JJ Table_NP 3_CD |_SYM Kinetic_JJ parameters_NNS of_IN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_JJ Prolonged_JJ treatment_NN of_IN Ap6A_NP and_CC Ap5A_NP identified_VBD the_DT major_JJ products_NNS as_IN adenosine_NN 5'-monophosphate_NN (_( AMP_NP )_) plus_CC adenosine_NN 5'-pentaphosphate_NN (_( p5A_NN )_) and_CC AMP_NN plus_CC adenosine_NN 5'-tetraphosphate_NN (_( p4A_NN )_) respectively_RB ._SENT In_IN neither_DT case_NN did_VBD p5A_NN or_CC p4A_NN accumulate_VBP as_IN these_DT are_VBP metabolised_VBN almost_RB as_RB rapidly_RB as_IN they_PP are_VBP formed_VBN ,_, p5A_NN being_VBG hydrolysed_VBN sequentially_RB to_TO p4A_NN then_RB ATP_NP ._SENT In_IN this_DT respect_NN ,_, hAps1_JJ and_CC hAps2_JJ show_VBP similar_JJ modes_NNS of_IN action_NN to_TO hDIPP-1_JJ and_CC hDIPP-2_JJ (_( S.T._NP Safrany_NP ,_, data_NNS not_RB shown_VBN )_) ._SENT Nudix_NP hydrolases_NNS have_VBP been_VBN found_VBN to_TO be_VB sensitive_JJ to_TO inhibition_NN by_IN fluoride_NN ._SENT Hydrolysis_NN of_IN Ap5A_NP by_IN hAps1_NN and_CC hAps2_NN was_VBD found_VBN to_TO be_VB inhibited_VBN non-competitively_JJ with_IN Ki_NP values_NNS of_IN 13.0_CD +-_NN 0.5_CD and_CC 30_CD +-_NN 1_CD muM_NN respectively_RB (_( data_NNS not_RB shown_VBN )_) ._SENT Despite_IN the_DT overall_JJ high_JJ degree_NN of_IN sequence_NN similarity_NN between_IN hAps1_NN ,_, hAps2_NN and_CC the_DT DIPPs_NP ,_, hAps1_NN and_CC hAps2_NN were_VBD found_VBN to_TO have_VB little_JJ activity_NN towards_IN PP-InsP5_NP or_CC [_SYM PP]2-InsP4_NP ._SENT hAps1_JJ and_CC hAps1-39N_NN showed_VBD first_JJ order_NN rate_NN constants_NNS (_( k-1_JJ )_) with_IN PP-InsP5_NP of_IN 19_CD +-_NN 4_CD and_CC 7_CD +-_NN 5_CD mug-1min-1_NN respectively_RB ._SENT Activity_NN of_IN hAps2_NN was_VBD similar_JJ to_TO that_DT of_IN hAps1_JJ ,_, with_IN a_DT k-1_NN =_SYM 13_CD +-_NN 6_CD mug-1min-1_NN ._SENT These_DT compare_NN with_IN k-1_JJ values_NNS of_IN 2200_CD ,_, 2000_CD and_CC 220_CD mug-1min-1_NN for_IN hDIPP-1_NN ,_, -2alpha_NN and_CC -2beta_NN respectively_RB ._SENT Km_NN and_CC kcat_NN values_NNS were_VBD determined_VBN for_IN each_DT of_IN the_DT proteins_NNS and_CC these_DT suggested_VBD that_IN the_DT reduction_NN in_IN activity_NN towards_IN PP-InsP5_NP compared_VBN with_IN hDIPP-1_NN and_CC hDIPP-2alpha_NN was_VBD primarily_RB due_JJ to_TO a_DT reduced_VBN affinity_NN for_IN this_DT substrate_NN ._SENT Activity_NN towards_IN [_SYM PP]2-InsP4_NN was_VBD even_RB weaker_JJR ._SENT hAps1_JJ and_CC hAps2_JJ gave_VBD k-1_NN =_SYM 1.0_CD +-_NN 0.2_CD and_CC 0.9_CD +-_NN 0.2_CD mug-1min-1_NN respectively_RB ._SENT hAps1-39N_NNS showed_VBD no_DT activity_NN towards_IN [_SYM PP]2-InsP4_NN under_IN the_DT conditions_NNS tested_VBD ._SENT In_IN contrast_NN ,_, hDIPP-1_JJ ,_, -2alpha_NN and_CC -2beta_NN gave_VBD k-1_JJ values_NNS of_IN 320_CD ,_, 90_CD and_CC 32_CD mug-1min-1_NN respectively_RB ,_, whereas_IN S._NP pombe_NN Aps1_NP and_CC S._NP cerevisiae_NP Ddp1p_NP showed_VBD similar_JJ activity_NN with_IN k-1_NP =_SYM 8.3_CD and_CC 1.7_CD mug-1min-1_NN respectively_RB ._SENT Tissue_NN distribution_NN |_SYM Analysis_NN of_IN the_DT tissue_NN distribution_NN of_IN hAps1_JJ and_CC hAps2_JJ gene_NN expression_NN was_VBD performed_VBN using_VBG PCR_NP and_CC human_JJ tissue_NN cDNA_NN samples_NNS ._SENT Using_VBG primers_NNS selective_JJ for_IN hAps1_NN ,_, PCR_NP products_NNS were_VBD readily_RB visible_JJ from_IN brain_NN ,_, pancreas_NN and_CC testis_NN and_CC less_RBR so_RB from_IN lung_NN ,_, thymus_NN ,_, prostate_NN ,_, ovary_NN ,_, small_JJ intestine_NN and_CC heart_NN (_( the_DT least_JJS )_) ._SENT Selective_JJ primers_NNS for_IN hAps2_JJ produced_VBN strong_JJ signals_NNS from_IN brain_NN and_CC liver_NN ,_, but_CC also_RB from_IN heart_NN ,_, placenta_NN ,_, lung_NN ,_, kidney_NN ,_, pancreas_NN ,_, spleen_NN ,_, prostate_NN ,_, testis_NN and_CC ovary_NN ._SENT No_DT signal_NN for_IN hAps1_NN was_VBD detected_VBN in_IN placenta_NN ,_, liver_NN ,_, skeletal_JJ muscle_NN ,_, kidney_NN ,_, spleen_NN ,_, colon_NN or_CC peripheral_JJ blood_NN leukocytes_NNS ._SENT Likewise_RB ,_, no_DT signal_NN for_IN hAps2_NN was_VBD found_VBN in_IN skeletal_JJ muscle_NN ,_, thymus_NN ,_, small_JJ intestine_NN ,_, colon_NN or_CC peripheral_JJ blood_NN leukocytes_NNS ._SENT A_DT number_NN of_IN tumour_NN cell_NN line_NN cDNA_NN samples_NNS were_VBD also_RB tested_VBN ;_: hAps1_JJ was_VBD present_JJ in_IN prostate_NN PC3_NN ,_, and_CC ovary_NN GI-102_NN cells_NNS ._SENT The_DT prostate_NN PC3_JJ cell_NN line_NN was_VBD also_RB found_VBN to_TO express_VB hAps2_NN ._SENT Tumour_NN cell_NN lines_NNS from_IN breast_NN GI-101_NP ,_, lung_NN LX-1_NP ,_, colon_NN CX-1_NP ,_, lung_NN GI-117_JJ ,_, colon_NN GI-112_NN and_CC pancreas_NN GI-103_NN were_VBD found_VBN to_TO express_VB neither_DT hAps1_JJ nor_CC hAps2_JJ ._SENT These_DT results_NNS are_VBP in_IN broad_JJ agreement_NN with_IN the_DT sources_NNS of_IN ESTs_NN for_IN these_DT two_CD protein_NN families_NNS ._SENT This_DT list_NN is_VBZ for_IN comparison_NN and_CC is_VBZ not_RB exhaustive_JJ ._SENT In_IN contrast_NN ,_, hDIPP-1_NN was_VBD found_VBN in_IN all_PDT the_DT tissues_NNS and_CC cell_NN types_NNS tested_VBN above_IN (_( S.T._NP Safrany_NP ,_, unpublished_JJ data_NNS )_) ._SENT Figure_NP 6_CD |_SYM Tissue_JJ distribution_NN of_IN hAps1_NN ,_, hAps2_NN and_CC beta-actin_NN ._SENT Tissue_NN distribution_NN of_IN hAps1_NN ,_, hAps2_NN and_CC beta-actin_NN ._SENT PCR_NP using_VBG human_JJ tissue_NN first-strand_NN cDNA_NN as_IN template_NN was_VBD performed_VBN with_IN primers_NNS specific_JJ for_IN beta-actin_NN and_CC for_IN hAps1_JJ or_CC hAps2_JJ ._SENT 35_CD cycles_NNS of_IN amplification_NN were_VBD used_VBN for_IN beta-actin_NN ,_, 40_CD cycles_NNS for_IN hAsp1_JJ and_CC hAps2_JJ ._SENT Whilst_IN an_DT exhaustive_JJ analysis_NN has_VBZ not_RB been_VBN performed_VBN for_IN hDIPP-2_NN ,_, it_PP was_VBD found_VBN to_TO be_VB highly_RB expressed_VBN in_IN heart_NN ,_, skeletal_JJ muscle_NN ,_, kidney_NN and_CC pancreas_NN ,_, and_CC weakly_RB expressed_VBN in_IN brain_NN ,_, placenta_NN lung_NN and_CC liver_NN ._SENT Subcellular_JJ localisation_NN |_SYM The_DT subcellular_JJ localisation_NN of_IN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_NN was_VBD investigated_VBN by_IN individual_JJ expression_NN of_IN the_DT three_CD proteins_NNS tagged_VBN at_IN the_DT N-terminus_NP with_IN EGFP_NP in_IN HEK293_NP and_CC PC12_NP cells_NNS ,_, and_CC visualisation_NN of_IN the_DT expressed_VBN fusion_NN proteins_NNS by_IN deconvolved_JJ fluorescence_NN microscopy_NN ._SENT These_DT results_NNS show_VBP that_IN in_IN both_DT cell_NN types_VBZ EGFP-tagged_JJ proteins_NNS showed_VBD a_DT cytosolic_JJ location_NN indistinguishable_JJ from_IN EGFP-hDIPP-2alpha_NP ,_, EGFP-hDIPP-2beta_NP and_CC EGFP_NP alone_RB (_( Fig._NN and_CC )_) ._SENT Similar_JJ data_NNS were_VBD obtained_VBN with_IN proteins_NNS tagged_VBN at_IN the_DT C-terminus_NP with_IN EGFP_NP (_( data_NN not_RB shown_VBN )_) ._SENT This_DT is_VBZ in_IN agreement_NN with_IN localisation_NN predicted_VBD using_VBG PSORTII_NP ._SENT Figure_NP 7_CD |_SYM Subcellular_JJ localisation_NN of_IN EGFP_NP ,_, EGFP-hDIPP-2_NP (_( alpha_NN and_CC beta_NN )_) and_CC hAps1_JJ and_CC hAps2_JJ ._SENT Subcellular_JJ localisation_NN of_IN EGFP_NP ,_, EGFP-hDIPP-2_NP (_( alpha_NN and_CC beta_NN )_) and_CC hAps1_JJ and_CC hAps2_JJ ._SENT Proteins_NNS fused_VBD to_TO the_DT C-terminus_NP of_IN EGFP_NP were_VBD expressed_VBN in_IN (_( a_DT )_) HEK293_NP or_CC (_( b_LS )_) PC12_JJ cells_NNS for_IN 24_CD h_NN and_CC visualised_VBN by_IN fluorescence_NN microscopy_NN ._SENT The_DT human_JJ genome_NN contains_VBZ at_IN least_JJS 18_CD Nudix_NP genes_NNS ,_, several_JJ of_IN which_WDT encode_VBP multiple_JJ products_NNS ,_, and_CC 9_CD Nudix_NP hydrolases_NNS have_VBP been_VBN characterised_VBN so_RB far_RB to_TO varying_VBG degrees_NNS (_( see_VB )_) ._SENT These_DT include_VBP hDIPP-1_JJ ,_, hDIPP-2alpha_NN and_CC hDIPP-2beta_NN ,_, encoded_VBN by_IN the_DT NUDT3_NP (_( hDIPP-1_JJ )_) and_CC NUDT4_NP (_( hDIPP-2alpha_NN and_CC hDIPP-2beta_NN )_) genes_NNS ,_, all_DT of_IN which_WDT hydrolyse_VBP both_CC the_DT higher_JJR order_NN diadenosine_NN polyphosphates_NNS and_CC diphosphoinositol_NN polyphosphates_NNS ._SENT In_IN this_DT report_NN ,_, we_PP describe_VBP the_DT cloning_VBG and_CC functional_JJ characterisation_NN of_IN hAps1_JJ and_CC hAps2_JJ ,_, two_CD new_JJ members_NNS of_IN the_DT DIPP_NP subfamily_NN with_IN a_DT novel_JJ pattern_NN of_IN expression_NN and_CC substrate_NN specificity_NN ._SENT A_DT polymorphism_NN of_IN hAps1_JJ (_( hAps1-39N_NN )_) has_VBZ also_RB been_VBN found_VBN ,_, its_PP$ activity_NN and_CC localisation_NN appearing_VBG broadly_RB similar_JJ to_TO those_DT of_IN hAps1_JJ ._SENT Unlike_IN the_DT other_JJ subfamily_NN members_NNS ,_, hAps1_JJ and_CC hAps2_JJ show_NN little_JJ activity_NN towards_IN diphosphoinositol_NN polyphosphates_NNS ,_, both_CC gene_NN products_NNS favouring_VBG diadenosine_NN polyphosphates_NNS ,_, ApnA_NP ,_, where_WRB n_NN =_SYM 5_CD or_CC 6_CD ._SENT In_IN each_DT case_NN ,_, Ap6A_NP binds_NNS with_IN higher_JJR affinity_NN than_IN Ap5A_NP ,_, whereas_IN the_DT kcat_NN for_IN the_DT latter_NN is_VBZ greater_JJR ._SENT Given_VBN that_IN no_DT other_JJ PP-InsP5_NP hydrolase_NN activity_NN was_VBD observed_VBN during_IN the_DT purification_NN of_IN rat_NN hepatic_NN DIPP_NP (_( most_JJS similar_JJ to_TO hDIPP-1_JJ )_) and_CC assuming_VBG that_DT tissue_NN expression_NN and_CC physiology_NN are_VBP broadly_RB conserved_VBN between_IN human_JJ and_CC rat_NN ,_, these_DT results_NNS would_MD suggest_VB that_IN Aps-like_JJ proteins_NNS do_VBP not_RB contribute_VB significantly_RB to_TO inositol_NN phosphate_NN metabolism_NN ._SENT Both_DT hAps1_JJ and_CC hAps2_JJ show_NN typical_JJ Nudix_NP hydrolase_NN requirements_NNS ,_, namely_RB an_DT alkaline_JJ pH_NN optimum_NN in_IN vitro_NN and_CC a_DT requirement_NN for_IN divalent_JJ cations_NNS ._SENT An_DT unusual_JJ feature_NN of_IN hAps1_NN and_CC hAps2_NN is_VBZ that_IN they_PP both_CC require_VB Mn2+_NP for_IN activation_NN ,_, and_CC that_IN Mg2+_NP is_VBZ without_IN effect_NN ._SENT Optimal_JJ [_SYM Mn2+_NP ]_SYM is_VBZ approximately_RB 4_CD mM_NNS ,_, which_WDT is_VBZ in_IN contrast_NN to_TO that_WDT estimated_VBD for_IN free_JJ intracellular_JJ [_SYM Mn2+_NN ]_SYM of_IN below_RB 0.5_CD muM_NN ._SENT Free_NN [_SYM Mn2+_NP ]_SYM in_IN our_PP$ in_IN vitro_NN assays_NNS was_VBD not_RB determined_VBN ._SENT It_PP is_VBZ well_RB acknowledged_VBN that_IN Mn2+_NP binds_VBZ serum_NN albumin_NN very_RB tightly_RB ,_, but_CC despite_IN this_DT we_PP would_MD anticipate_VB free_RB [_SYM Mn2+_NN ]_SYM in_IN the_DT assays_NNS to_TO be_VB far_RB in_IN excess_NN of_IN intracellular_JJ levels_NNS ._SENT It_PP is_VBZ known_VBN that_IN the_DT activity_NN of_IN metal_NN ion-requiring_VBG enzymes_NNS in_IN different_JJ cellular_JJ compartments_NNS can_MD be_VB regulated_VBN through_IN the_DT controlled_VBN trafficking_NN of_IN these_DT ions_NNS and_CC therefore_RB through_IN the_DT controlled_VBN access_NN of_IN these_DT enzymes_NNS to_TO their_PP$ required_JJ ions_NNS ._SENT This_DT principle_NN has_VBZ been_VBN most_RBS thoroughly_RB studied_VBN in_IN the_DT case_NN of_IN Ca2+_NP ,_, although_IN analogous_JJ observations_NNS have_VBP been_VBN made_VBN with_IN Cu2+_NP and_CC Mn2+_NP ._SENT Since_IN the_NP [_SYM Mn2+_NN ]_SYM throughout_IN the_DT cell_NN is_VBZ known_VBN to_TO be_VB non-uniform_JJ ,_, the_DT unusual_JJ requirement_NN of_IN the_DT hAps_NNS enzymes_NNS suggests_VBZ a_DT possible_JJ mechanism_NN of_IN regulation_NN through_IN access_NN to_TO this_DT ion_NN ._SENT Several_JJ biochemically_NNS distinct_JJ Ap5/6A_NP hydrolases_NNS have_VBP been_VBN described_VBN previously_RB ._SENT S._NP pombe_NN Aps1_NP ,_, S._NP cerevisiae_NP Ddp1p_NP and_CC hDIPP-1_JJ and_CC hDIPP-2_JJ have_VBP all_RB been_VBN shown_VBN to_TO metabolise_VB Ap5A_NP and_CC Ap6A_NP ._SENT The_DT activities_NNS of_IN hAps1_JJ and_CC hAps2_JJ towards_IN Ap5A_NP and_CC Ap6A_NP are_VBP comparable_JJ to_TO hDIPP-1_JJ ,_, but_CC their_PP$ activities_NNS towards_IN the_DT diphosphoinositol_NN polyphosphates_VBZ PP-InsP5_NP and_NP [_SYM PP]2-InsP4_NP are_VBP greatly_RB reduced_VBN ,_, thus_RB making_VBG them_PP some_RB 100_CD --_: 300-fold_JJ more_RBR selective_JJ towards_IN Ap5A_NP and_CC Ap6A_NP than_IN hDIPP-1_JJ or_CC hDIPP-2_JJ ._SENT S._NP pombe_NN Aps1_NP and_CC S._NP cerevisiae_NP Ddp1p_NP ,_, the_DT sole_JJ representatives_NNS of_IN the_DT DIPP_NP subfamily_NN in_IN the_DT two_CD yeast_NN genomes_NNS ,_, appear_VBP to_TO favour_VB the_DT diphosphoinositol_NN polyphosphates_NNS ._SENT Their_PP$ modes_NNS of_IN action_NN have_VBP been_VBN shown_VBN to_TO differ_VB from_IN their_PP$ mammalian_JJ counterparts_NNS ._SENT The_DT major_JJ products_NNS of_IN Ap6A_NP hydrolysis_NN by_IN S._NP pombe_NN Aps1_NP and_CC S._NP cerevisiae_NP Ddp1p_NP are_VBP ADP_NP and_CC p4A_NP ._SENT As_RB with_IN hDIPP-1_JJ and_CC hDIPP-2_JJ (_( Safrany_NP ,_, data_NNS not_RB shown_VBN )_) ,_, hAps1_JJ and_CC hAps2_JJ produced_VBN AMP_NN and_CC p5A_NN as_IN major_JJ products_NNS ._SENT With_IN Ap5A_NP as_IN substrate_NN ,_, S._NP pombe_NN Aps1_NP favoured_VBD the_DT production_NN of_IN ADP_NP plus_CC ATP_NP ,_, whereas_IN S._NP cerevisiae_NP Ddp1p_NP favoured_VBD production_NN of_IN AMP_NP and_CC p4A_NP ._SENT In_IN this_DT respect_NN hAps1_NN and_CC hAps2_NN as_RB well_RB as_IN hDIPP-1_JJ and_CC hDIPP-2_JJ resemble_VBP Ddp1p_NP ._SENT Due_JJ to_TO the_DT chromosomal_JJ proximity_NN of_IN Aps1_NP and_CC Aps2_NP ,_, and_CC the_DT greater_JJR degree_NN of_IN sequence_NN identity_NN with_IN each_DT other_JJ than_IN with_IN the_DT Aps-like_JJ genes_NNS from_IN mouse_NN ,_, rat_NN or_CC cow_NN ,_, it_PP seems_VBZ likely_RB that_IN this_DT gene_NN pair_NN has_VBZ arisen_VBN as_IN the_DT result_NN of_IN a_DT recent_JJ gene_NN duplication_NN event_NN on_IN the_DT short_JJ arm_NN of_IN the_DT X_NP chromosome_NN ._SENT A_DT popular_JJ view_NN of_IN the_DT evolution_NN of_IN catalytic_JJ motifs_NNS envisages_VBZ the_DT duplication_NN of_IN relatively_RB non-specific_JJ progenitors_NNS followed_VBN by_IN adaptation_NN to_TO perform_VB special_JJ tasks_NNS ,_, and_CC the_DT Nudix_NP hydrolase_NN motif_NN appears_VBZ to_TO be_VB a_DT good_JJ illustration_NN of_IN this_DT process_NN ._SENT The_DT existence_NN of_IN multiple_JJ forms_NNS of_IN these_DT enzymes_NNS would_MD suggest_VB that_IN the_DT diadenosine_NN polyphosphates_NNS have_VBP significant_JJ biological_JJ functions_NNS ,_, with_IN the_DT specialised_VBN task_NN of_IN hAps1_NN and/or_CC hAps2_NN being_VBG the_DT regulation_NN of_IN Ap5A_NP and_CC Ap6A_NP levels_NNS ._SENT Previously_RB ,_, the_DT human_JJ DIPP_NP family_NN comprised_VBD hDIPP-1_JJ ,_, a_DT ubiquitous_JJ enzyme_NN able_JJ to_TO hydrolyse_VB both_DT inositol_NN phosphates_NNS and_CC diadenosine_NN polyphosphates_NNS ,_, and_CC hDIPP-2alpha_NP and_CC -2beta_NP ,_, which_WDT are_VBP predominantly_RB diphosphoinositol_JJ polyphosphate_NN phosphohydrolases_NNS highly_RB expressed_VBD in_IN heart_NN ,_, skeletal_JJ muscle_NN ,_, kidney_NN and_CC pancreas_NN ._SENT We_PP have_VBP now_RB identified_VBN two_CD further_JJR members_NNS ,_, hAps1_NN and_CC hAps2_NN ,_, which_WDT have_VBP high_JJ selectivity_NN towards_IN the_DT diadenosine_NN polyphosphates_NNS ._SENT The_DT distinction_NN between_IN DIPP_NP and_CC ApnA_NP hydrolase_NN activities_NNS reinforces_VBZ the_DT importance_NN of_IN Q86_NP in_IN DIPP-2beta_NP and_CC the_DT role_NN of_IN Q85_NP in_IN hAps1_JJ and_CC hAps2_JJ ._SENT The_DT addition_NN of_IN this_DT amino_NN acid_NN in_IN hDIPP-2_NN has_VBZ been_VBN previously_RB shown_VBN to_TO have_VB a_DT substantial_JJ negative_JJ effect_NN upon_IN its_PP$ activity_NN towards_IN diphosphoinositol_NN polyphosphates_NNS ,_, whereas_IN Ap5A_NP hydrolase_NN activity_NN was_VBD increased_VBN ._SENT The_DT expression_NN of_IN hAps1_NN and_CC hAps2_NN is_VBZ also_RB restricted_VBN ._SENT Of_IN the_DT tissues_NNS tested_VBD ,_, only_JJ pancreas_NN showed_VBD high_JJ levels_NNS of_IN hDIPP-2_JJ and_CC hAps1_JJ ,_, and_CC only_JJ heart_NN showed_VBD high_JJ levels_NNS of_IN hDIPP-2_NN and_CC hAps2_NN ,_, although_IN ESTs_NN were_VBD found_VBN suggesting_VBG that_IN hDIPP-2_NN is_VBZ expressed_VBN in_IN testis_NN ,_, ovary_NN and_CC prostate_NN ._SENT The_DT presence_NN of_IN hAps1_JJ and_CC hAps2_JJ in_IN such_PDT a_DT variety_NN of_IN tissues_NNS suggests_VBZ that_IN Ap5A_NP and_CC Ap6A_NP may_MD have_VB roles_NNS other_JJ than_IN as_RB secreted_VBN molecules_NNS ._SENT We_PP find_VBP that_IN hAps1_NN is_VBZ present_JJ in_IN the_DT pancreas_NN ,_, but_CC there_EX is_VBZ no_DT suggestion_NN that_IN it_PP is_VBZ secreted_VBN ._SENT For_IN this_DT reason_NN ,_, hAps1_JJ and_CC hAps2_JJ are_VBP expected_VBN to_TO control_VB intracellular_JJ Ap5A_NP and_CC Ap6A_NP levels_NNS ._SENT In_IN conclusion_NN ,_, we_PP have_VBP identified_VBN two_CD human_JJ Nudix_NP hydrolases_NNS that_WDT share_VBP a_DT novel_JJ substrate_NN specificity_NN ,_, metabolising_VBG predominantly_RB Ap5A_NP and_CC Ap6A_NP ._SENT These_DT two_CD gene_NN products_NNS complement_VB the_DT activity_NN of_IN previously_RB described_VBN members_NNS of_IN the_DT DIPP_NP family_NN ,_, and_CC reinforce_VB the_DT concept_NN of_IN Ap5A_NP and_CC Ap6A_NP acting_VBG as_IN intracellular_JJ messengers_NNS ._SENT NRL_NP performed_VBD the_DT cloning_VBG and_CC subcloning_VBG ,_, determined_VBN subcellular_JJ localisation_NN in_IN mammalian_JJ cells_NNS ,_, participated_VBN in_IN sequence_NN analysis_NN and_CC obtained_VBD the_DT genomic_JJ alignment_NN ._SENT AGMcL_NN assisted_VBN in_IN the_DT writing_NN of_IN the_DT manuscript_NN ._SENT STS_NP conceived_VBD of_IN this_DT study_NN ,_, prepared_VBN recombinant_JJ enzymes_NNS ,_, performed_VBN enzyme_NN assays_NNS ,_, determined_VBD the_DT tissue_NN distribution_NN ,_, participated_VBN in_IN sequence_NN analysis_NN and_CC drafted_VBD the_DT manuscript_NN ._SENT All_DT authors_NNS read_VBD and_CC approved_VBD the_DT final_JJ manuscript_NN ._SENT Materials_NPS |_SYM Ap4G_NP ,_, Ap5G_NP and_CC p4A_NP were_VBD purchased_VBN from_IN Jena_NP Bioscience_NP ,_, Jena_NP ,_, Germany_NP ._SENT Other_JJ nucleotides_NNS were_VBD purchased_VBN from_IN Sigma_NP ._SENT Non-radioactive_JJ PP-InsP5_NN was_VBD a_DT kind_NN gift_NN from_IN J.R._NP Falck_NP (_( University_NP of_IN Texas_NP Southwestern_NP Medical_NP Center_NP ,_, Dallas_NP ,_, TX_NP ,_, USA_NP )_) ._SENT [_SYM 3H]-PP-InsP5_JJ and_CC [_SYM 3H]-[PP]2-InsP4_JJ were_VBD prepared_VBN as_IN previously_RB described_VBN ._SENT Cloning_VBG and_CC plasmid_NN construction_NN |_SYM PCR_NP products_NNS corresponding_JJ to_TO the_DT hAps1_JJ sequence_NN were_VBD amplified_VBN from_IN a_DT human_JJ testis_NN library_NN (_( Clontech_NP )_) ,_, using_VBG the_DT primers_NNS SSD019_NP (_( 5'-ggcaggatccaagtgcaaacccaaccagacg-3_NP '_POS )_) and_CC SSD020_NP (_( 5'-ggcaggatccttagggatcgctatctggcg-3_NP '_POS )_) (_( BamHI_NP sites_NNS are_VBP underlined_VBN )_) ._SENT PCR_NP was_VBD carried_VBN out_IN using_VBG a_DT HiFidelity_NP Expand_NP Kit_NP (_( Roche_NP )_) ,_, and_CC the_DT products_NNS cloned_VBN into_IN the_DT vector_NN pCR2.1TOPO_NN (_( Invitrogen_NP )_) and_CC sequenced_JJ ._SENT Surprisingly_RB ,_, three_CD variant_JJ sequences_NNS were_VBD found_VBN (_( termed_VBD hAps1_JJ ,_, hAps1-39N_NN and_CC hAps2_NN )_) ._SENT These_DT were_VBD subcloned_VBN as_IN BamHI_NP fragments_NNS into_IN the_DT BamHI_NP site_NN of_IN pGEX-6P1_JJ (_( Amersham_NP Pharmacia_NP Biotech_NP )_) (_( starting_VBG at_IN K2_NP ,_, to_TO compare_VB with_IN K3_NP of_IN hDIPP-1_JJ and_CC hDIPP-2_JJ )_) and_CC fully_RB re-sequenced_JJ ._SENT The_DT 3_CD '_POS nucleotide_NN of_IN SSD019_NP introduced_VBD a_DT silent_JJ mutation_NN into_IN hAps2_NN ,_, and_CC was_VBD allowed_VBN to_TO remain_VB ._SENT Likewise_RB ,_, SSD020_NP also_RB introduced_VBD a_DT silent_JJ mutation_NN into_IN the_DT stop_NN codon_NN of_IN hAps2_NN ._SENT This_DT was_VBD also_RB allowed_VBN to_TO remain_VB ._SENT Vectors_NNS for_IN the_DT expression_NN of_IN Nudix_NP hydrolase_NN proteins_NNS fused_VBD to_TO the_DT C-terminus_NP of_IN Enhanced_NP Green_NP Fluorescent_NP Protein_NP (_( EGFP_NP )_) were_VBD produced_VBN by_IN ligating_VBG a_DT cDNA_NN encoding_VBG each_DT protein_NN as_IN a_DT BamHI_NP digestion_NN fragment_NN from_IN the_DT GST-fusion_NP vectors_NNS described_VBD above_IN ,_, into_IN pEGFP-C1_JJ (_( Clontech_NP )_) previously_RB digested_VBN with_IN BglII_NP and_CC BamHI_NP ._SENT Bioinformatics_NN |_SYM Multiple_JJ sequence_NN alignments_NNS were_VBD performed_VBN using_VBG MAP_NP and_CC BoxShade_NP ,_, both_DT run_NN by_IN EMBnet_NP ,_, Lausanne_NP ,_, Switzerland_NP ._SENT Blast_NN searches_NNS of_IN EST_NN and_CC genomic_JJ databases_NNS were_VBD performed_VBN using_VBG the_DT facilities_NNS provided_VBN by_IN NCBI_NP ,_, Bethesda_NP ,_, MD_NP ,_, USA_NP ._SENT Expression_NN and_CC purification_NN of_IN hAps1_JJ ,_, hAps1-39N_NNS and_CC hAps2_NNS |_SYM Full-length_JJ hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_NN were_VBD expressed_VBN and_CC purified_VBN from_IN E._NP coli_NNS as_IN GST-fusion_NN proteins_NNS ._SENT Expression_NN plasmids_NNS based_VBN on_IN pGEX-6P1_NN were_VBD transformed_VBN into_IN E._NP coli_NNS strain_VBP BL21_NP ,_, and_CC induced_VBN at_IN 26C_JJ overnight_JJ with_IN 100_CD muM_NN IPTG_NN ._SENT Cells_NNS were_VBD harvested_VBN in_IN buffer_NN A_NP (_( 20_CD mM_NP Tris_NP ,_, 150_CD mM_NP NaCl_NP ,_, 2_CD mM_NP DTT_NP ,_, 0.1_CD mM_NP EGTA_NP ,_, pH_NN 7.5_CD )_) ,_, supplemented_VBN with_IN 5_CD mug/ml_NN leupeptin_NN and_CC 1_CD mug/ml_NN aprotinin_NN ,_, and_CC disrupted_VBN by_IN sonication_NN (_( 3_CD x_SYM 15s_JJ )_) ._SENT Particulate_JJ matter_NN was_VBD removed_VBN by_IN centrifugation_NN ._SENT The_DT supernatant_JJ was_VBD applied_VBN to_TO (_( and_CC subsequently_RB eluted_VBN from_IN )_) a_DT 5_CD mm_NN x_SYM 5_CD cm_NN Glutathione_NP Sepharose_NP 4_CD Fast_NP Flow_NP column_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) at_IN a_DT flow_NN rate_NN of_IN 1_CD ml/min_NN ._SENT The_DT column_NN was_VBD washed_VBN for_IN 5_CD min_NN with_IN buffer_NN A._NP Bound_NP protein_NN was_VBD eluted_VBN with_IN a_DT gradient_NN generated_VBN by_IN mixing_VBG buffer_NN A_DT with_IN buffer_NN B_NN (_( buffer_VB A_DT plus_JJ 25_CD mM_NP glutathione_NN ,_, pH_NN 7.5_CD )_) as_RB follows_VBZ :_: 0-10_CD min_NN ,_, 0-50_CD %_NN buffer_NN B_NP ;_: 10-13_CD min_NN ,_, 100_CD %_NN buffer_JJR B._NP Fractions_NNS containing_VBG pure_JJ hAps1_NN ,_, hAps1-39N_NN or_CC hAps2_NN were_VBD supplemented_VBN with_IN glycerol_NN (_( 10_CD %_NN v/v_NN final_JJ )_) ,_, and_CC stored_VBD at_IN -80C_NN ._SENT Tissue_NN distribution_NN |_SYM The_DT tissue_NN distribution_NN of_IN hAps1_JJ and_CC hAps2_JJ expression_NN was_VBD determined_VBN by_IN PCR_NP from_IN human_JJ tissue_NN cDNA_NN samples_NNS (_( human_JJ cDNA_NN panels_NNS ,_, Clontech_NP )_) and_CC human_JJ cDNA_NN libraries_NNS (_( testis_NN from_IN Clontech_NP ,_, brain_NN from_IN Dr_NP Peter_NP Cheung_NP of_IN the_DT MRC_NP Protein_NP Phosphorylation_NP Unit_NP ,_, Wellcome_NP Trust_NP Biocentre_NP ,_, Dundee_NP ,_, Scotland_NP ,_, UK_NP )_) ._SENT beta-Actin-specific_JJ and_CC hAps1_JJ and_CC hAps2-specific_JJ primers_NNS were_VBD used_VBN ._SENT The_DT hAps1_JJ primers_NNS were_VBD SSD049_NP (_( 5'-cgtcttcgaacagaaccaggatcg-3_NP '_POS )_) ,_, and_CC SSD045_NP (_( 5'-caaaagccacacacatggtgcc-3_NP '_POS )_) and_CC the_DT hAps2_JJ primers_NNS were_VBD SSD050_NP (_( 5'-cgtcttcgaacagaaccaggaccc-3_NP '_POS )_) and_CC SSD046_NP (_( 5'-gtgcaacaacctggagaatagtcattgta-3_NP '_POS )_) ._SENT Primers_NNS SSD045_NP and_CC SSD046_NP were_VBD selective_JJ for_IN the_DT 3_CD '_POS untranslated_JJ regions_NNS of_IN hAsp1_JJ and_CC hAsp2_JJ respectively_RB ._SENT beta-Actin_NN cDNA_NNS was_VBD amplified_VBN using_VBG beta_JJ AS_NP (_( 5'-acactgtgcccatctacgaggg-3_NP '_POS )_) and_CC beta_JJ AA_NP (_( 5'ccttctgcatcctgtcagcaatg-3_NP '_POS )_) ._SENT PCR_NP was_VBD carried_VBN out_IN using_VBG a_DT HiFidelity_NP Expand_NP Kit_NP (_( Roche_NP )_) ,_, and_CC cDNA_NN samples_NNS from_IN heart_NN ,_, brain_NN ,_, placenta_NN ,_, lung_NN ,_, liver_NN ,_, skeletal_JJ muscle_NN ,_, kidney_NN ,_, pancreas_NN (_( human_JJ MTC_NP panel_NN I_NP #K1420-1_NP ,_, Clontech_NP )_) ,_, spleen_NN ,_, thymus_NN ,_, prostate_NN ,_, testis_NN ,_, ovary_NN ,_, small_JJ intestine_NN ,_, colon_NN ,_, peripheral_JJ blood_NN leukocytes_NNS (_( human_JJ MTC_NP Panel_NP II_NP #K1421-1_NP ,_, Clontech_NP )_) ._SENT The_DT following_VBG tumour_NN cell_NN lines_NNS were_VBD also_RB tested_VBN :_: breast_NN GI-101_NP ,_, lung_NN LX-1_NP ,_, colon_NN CX-1_NP ,_, lung_NN GI-117_JJ ,_, prostate_NN PC3_NP ,_, colon_NN GI-112_NP ,_, ovary_NN GI-102_NN and_CC pancreas_NN GI-103_NP (_( human_JJ MTC_NP Tumor_NP Panel_NP #K1422-1_NP ,_, Clontech_NP )_) ._SENT Subcellular_JJ localisation_NN |_SYM The_DT subcellular_JJ localisation_NN of_IN hAps1_NN ,_, hAps1-39N_NN and_CC hAps2_JJ proteins_NNS fused_VBN to_TO EGFP_NP was_VBD investigated_VBN using_VBG transfected_JJ HEK_NP 293_CD epithelial_JJ cells_NNS and_CC PC12_JJ pheochromocytoma_NN cells_NNS ._SENT PC12_JJ cells_NNS were_VBD grown_VBN in_IN DMEM/5_NP %_NN foetal_JJ bovine_JJ serum/5_NN %_NN horse_NN serum_NN ._SENT HEK293_NP were_VBD grown_VBN in_IN DMEM/10_NP %_NN foetal_JJ bovine_JJ serum_NN ._SENT Both_CC cell_NN types_NNS were_VBD grown_VBN on_IN coverslips_NNS and_CC transfected_JJ using_VBG Fugene-6_NP (_( Roche_NP )_) with_IN expression_NN vectors_NNS for_IN each_DT Nudix_NP hydrolase_NN fused_VBD to_TO the_DT C-terminus_NP of_IN EGFP_NP ._SENT 24_CD hours_NNS after_IN transfection_NN ,_, cells_NNS were_VBD observed_VBN using_VBG a_DT Leica_NP inverted_JJ stage_NN fluorescence_NN microscope_NN and_CC a_DT Hamamatsu_NP Orca_NP charge-coupled-device_NN camera_NN ._SENT Images_NNS were_VBD analysed_VBN using_VBG Improvision_NP OpenLab_NP deconvolution_NN software_NN ._SENT Enzyme_NN assays_NNS |_SYM For_IN the_DT analysis_NN of_IN nucleotide_NN metabolism_NN ,_, assays_NNS were_VBD performed_VBN as_IN previously_RB described_VBN ,_, unless_IN otherwise_RB stated_VBN ._SENT The_DT UV-absorbing_NP (_( 260_CD nm_NN )_) nucleotide_NN reaction_NN products_NNS were_VBD analysed_VBN using_VBG a_DT 4.6_CD x_SYM 125_CD mm_NN Partisphere_NP 5_CD mum_JJ SAX_NP HPLC_NP column_NN ._SENT Substrates_NNS and_CC products_NNS were_VBD eluted_VBN at_IN 1_CD ml/min_NN by_IN the_DT following_VBG gradient_NN generated_VBN by_IN mixing_VBG water_NN with_IN buffer_NN C_NP (_( 1.3_CD M_NP (NH4)2HPO4_NN ,_, pH_NN 4.8_CD with_IN H3PO4_NP )_) :_: 0-5_CD min_NN ,_, 0_CD %_NN buffer_NN C_NP ;_: 5-55_CD min_NN ,_, 0-50_CD %_NN buffer_NN C_NP ;_: 56-70_CD min_NN ,_, 0_CD %_NN buffer_NN C._NP pH_NN optima_NNS of_IN recombinant_JJ enzymes_NNS were_VBD determined_VBN in_IN a_DT series_NN of_IN buffers_NNS comprising_VBG 1_CD mM_NP MnCl2_NP ,_, 100_CD mug/ml_NN BSA_NP and_CC 15_CD mM_NP MES_NP ,_, 15_CD mM_NP HEPES_NP or_CC 15_CD mM_NP Tris_NP (_( pH_NN 6-9_CD with_IN HCl_NP or_CC NaOH_NP )_) ._SENT Divalent_JJ ion-dependency_NN was_VBD determined_VBN in_IN a_DT buffer_NN comprising_VBG 50_CD mM_NP HEPES_NP ,_, 100_CD mug/ml_NN BSA_NP ,_, pH_NN 7.6_CD ,_, and_CC 50_CD muM-10mM_NNS (_( where_WRB possible_JJ )_) divalent_JJ metal_NN as_IN the_DT chloride_NN salt_NN ._SENT Inositol_NN phosphate_NN metabolism_NN was_VBD determined_VBN exactly_RB as_RB described_VBN previously_RB ._SENT Km_NN and_CC kcat_NN values_NNS were_VBD determined_VBN by_IN hyperbolic_JJ regression_NN analysis_NN ._SENT During_IN the_DT reviewing_VBG of_IN this_DT manuscript_NN a_DT paper_NN was_VBD submitted_VBN and_CC accepted_VBN in_IN the_DT Journal_NP of_IN Biological_NP Chemistry_NP (_( K_NP Hidaka_NP ,_, JJ_NN Caffrey_NP ,_, L_NP Hua_NP ,_, T_NN Zhang_NP ,_, JR_NP Falck_NP ,_, GC_NP Nickel_NP ,_, L_NP Carrel_NP ,_, LD_NP Barnes_NP ,_, SB_NP Shears_NP :_: An_DT adjacent_JJ pair_NN of_IN human_JJ NudT_NP genes_NNS on_IN chromosome_NN X_NN are_VBP preferentially_RB expressed_VBN in_IN testis_NN and_CC encode_VB two_CD new_JJ isoforms_NNS of_IN diphosphoinositol_NN polyphosphate_NN phosphohydrolase_NN ._SENT J_NP Biol_NP Chem_NP in_IN press_NN )_) ._SENT DIPP-3beta_NP corresponds_VBZ to_TO hAps1_NN ,_, whereas_IN DIPP-3alpha_NP corresponds_VBZ to_TO hAps2_NN ._SENT 